Lamotrigin Actavis

Lamotrigine, the active ingredient in Lamotrigin Actavis, is an anticonvulsant presented as an oral tablet for oral use. It is used to manage seizures in epilepsy and to stabilize mood in bipolar disorder, helping patients achieve better seizure control and mood regulation.

GNH USA supplies Lamotrigin Actavis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for global healthcare providers. With a focus on regulatory compliance and timely delivery, GNH USA supports the therapeutic needs of patients across diverse markets.

Lamotrigine is an anticonvulsant that modulates neuronal excitability in seizure disorders and mood disorders. - Epilepsy (broad): Controls various seizure types, including focal and generalized seizures. - Bipolar disorder: Stabilizes mood and reduces frequency of manic and depressive episodes. - Adjunctive therapy for refractory seizures: Used when seizures are not adequately controlled by other antiepileptic drugs.

Lamotrigine may cause a range of adverse reactions, varying from mild to serious. Common Side Effects: - Dizziness: Light‑headed sensation or loss of balance. - Headache: Mild to moderate head pain. - Nausea: Stomach discomfort or urge to vomit. - Rash: Skin redness or itching. - Fatigue: General feeling of tiredness. - Blurred vision: Temporary visual disturbances. Serious or Rare Side Effects: - Stevens‑Johnson syndrome: Severe skin reaction requiring immediate medical attention. - Toxic epidermal necrolysis: Life‑threatening skin detachment. - Aseptic meningitis: Inflammation of the meninges without infection. - Blood dyscrasias: Abnormal blood cell counts, such as agranulocytosis. - Hepatotoxicity: Liver injury indicated by elevated enzymes. - Suicidal thoughts: Emergence of depressive or suicidal ideation.

When prescribing lamotrigine, clinicians should consider several precautionary measures to ensure patient safety. - Initiate therapy at low dose: Gradually increase to reduce risk of rash. - Monitor skin reactions: Discontinue immediately if severe rash develops. - Assess hepatic function: Use caution in patients with liver impairment. - Review concomitant drugs: Adjust dose when used with enzyme‑inducing antiepileptics. - Counsel on pregnancy: Discuss potential risks and benefits with women of childbearing potential. - Store at ambient temperature: Keep tablets in original container, protect from moisture and heat.

Lamotrigine interacts with several medications, influencing its plasma levels and safety profile. Major Interactions (Avoid): - Valproic acid: Increases lamotrigine concentrations, raising risk of severe rash. - Carbamazepine: Decreases lamotrigine levels, potentially reducing efficacy. - Phenytoin: Lowers lamotrigine exposure, may require dose adjustment. Moderate Interactions (Monitor Closely): - Oral contraceptives: May increase lamotrigine clearance, necessitating dose review. - Phenobarbital: Reduces lamotrigine levels, monitor seizure control. - Topiramate: May modestly decrease lamotrigine concentrations, observe therapeutic response.